Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece et al. · British Journal of Haematology · 1998 · 1.5K citations

Medicine, Hematology, Oncology +17

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

DG Maloney, A.J. Grillo-López, David Bodkin et al. · Journal of Clinical Oncology · 1997 · 638 citations

Pharmacy, Hematology, Pharmacokinetics +17

HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA

T MCELWAIN · The Lancet · 1983 · 512 citations

Medicine, Hematology, Oncology +10

Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics

Ramón García‐Sánz, Marcos González, María Dolores Tabernero et al. · Blood · 1999 · 317 citations · Full text

Medicine, Hematology, Oncology +16

Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B‐lymphocyte clones in a polyclonal population

M. J. Brisco, Lindi Tan, Annette Orsborn et al. · British Journal of Haematology · 1990 · 214 citations

Life Sciences, Hematology, Molecular Biology +15